Molecular Templates Receivables

Molecular Templates (MTEM) currently reports a receivables of $800K as of June 2024. That compares with $270K in the prior-year period — up 190.1% year over year. Use the charts on this page to explore Molecular Templates's receivables history and peer comparisons.

Molecular Templates's receivables increased from $270K to $800K — a 190.1% year-over-year increase (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Molecular Templates reported $800K in receivables as of June 2024. That compares with $270K in the prior-year period — up 190.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $800K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Molecular Templates, and consider following MTEM for alerts when major investors trade the stock.

Molecular Templates is classified in the Healthcare sector. On receivables, it currently shows $800K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MTEM with unrelated industries.